TANDEM DIABETES CARE INC's ticker is TNDM and the CUSIP is 875372203. A total of 274 filers reported holding TANDEM DIABETES CARE INC in Q1 2023. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8 | -11.1% | 371 | 0.0% | 0.00% | – |
| Q2 2023 | $9 | -55.0% | 371 | -25.1% | 0.00% | -100.0% |
| Q1 2023 | $20 | -31.0% | 495 | -22.9% | 0.00% | -50.0% |
| Q4 2022 | $29 | -99.9% | 642 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $31,000 | -39.2% | 642 | -25.6% | 0.00% | -33.3% |
| Q2 2022 | $51,000 | -70.9% | 863 | -42.7% | 0.00% | -62.5% |
| Q1 2022 | $175,000 | +80.4% | 1,506 | +134.6% | 0.01% | +100.0% |
| Q4 2021 | $97,000 | +26.0% | 642 | 0.0% | 0.00% | +33.3% |
| Q3 2021 | $77,000 | -71.3% | 642 | -76.7% | 0.00% | -75.0% |
| Q2 2021 | $268,000 | +7.2% | 2,757 | -2.8% | 0.01% | -7.7% |
| Q1 2021 | $250,000 | -11.0% | 2,836 | -3.2% | 0.01% | -18.8% |
| Q4 2020 | $281,000 | -10.2% | 2,929 | +5.9% | 0.02% | -20.0% |
| Q3 2020 | $313,000 | +99.4% | 2,765 | +73.9% | 0.02% | +81.8% |
| Q2 2020 | $157,000 | -42.5% | 1,590 | -62.6% | 0.01% | -52.2% |
| Q1 2020 | $273,000 | -23.5% | 4,246 | -29.1% | 0.02% | -4.2% |
| Q4 2019 | $357,000 | – | 5,985 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 474,929 | $22,725,000 | 3.92% |
| Soleus Capital Management, L.P. | 415,200 | $19,867,000 | 2.70% |
| First Light Asset Management, LLC | 485,620 | $23,237,000 | 2.35% |
| Eagle Health Investments LP | 196,400 | $9,398,000 | 2.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 218,049 | $10,434,000 | 1.66% |
| EMINENCE CAPITAL, LP | 1,590,787 | $76,119,000 | 1.59% |
| Brown Capital Management | 2,010,230 | $96,190,000 | 1.35% |
| Chicago Capital, LLC | 479,873 | $22,962,000 | 1.33% |
| Intrinsic Edge Capital Management LLC | 247,391 | $11,838,000 | 1.29% |
| Bellevue Group AG | 1,566,015 | $74,933,000 | 1.08% |